The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.
Please enter a word or phrase into the search box to find relevant materials. If you want to search for a phrase, please use quotes, eg “Macmillan Cancer Support”, “Breast cancer”. If you have any questions about the web directory please contact Sue Hawkins firstname.lastname@example.org
Daratumumab, also known as Darzalex®, is a monoclonal antibody drug used in the treatment of myeloma. This booklet describes what it is, how it works, how it is given, and the possible side-effects.
Steroids are often part of treatment for Hodgkin and non-Hodgkin lymphoma, including cutaneous (skin) lymphoma. This factsheet explains what steroids are, when and how they might be given, possible side effects, and the precautions that people should take when they are on steroids.
This treatment guide has information about thalidomide, a drug used in the treatment of myeloma. It explains what it is, how it works, and how it is given, and describes the possible side-effects.
This factsheet has information on on immunotherapy, a type of treatment being investigated in myeloma. It explains what imunotherapy treatment is, how it works, and the current evidence to support its use in the treatment of myeloma. It describes the main immunotherapies (monoclonal antibody drugs; CAR-T cell treatments; and oncolytic viruses) and their known possible side-effects, and the availability of immunotherapy treatment in the UK.
Skin problems can be a symptom of lymphoma. They can also be a side effect of some treatments. This factsheet has suggestions to help you manage dry, sore and itchy skin. Contents: Skin problems as a symptom of lymphoma; Skin problems as a side effect of treatment; Managing sore, dry and itchy skin.
This factsheet describes the use of ibrutinib for the treatment of certain types of lymphoma (relapsed or refractory mantle cell lymphoma; relapsed or refractory CLL; CLL and a 17p deletion). It covers what ibrutinib is, who can have it and who cannnot, its benefits, how it is given, side effects and precautions while being treated.
This leaflet describes what happens when proton beam therapy is given, and the possible side effects.
This booklet describes autologous stem cell transplant in detail.
Bortezomib, also known as Velcade®, is a proteasome inhibitor drug used in the treatment of myeloma. This factsheet describes what it is, how it works, how it is given, and possible side-effects.
Breast Cancer Care
Zoledronic acid is a drug that’s given to reduce the risk of breast cancer spreading to the bones and other parts of the body. This booklet explains what it is, who might be offered it and the side effects it can cause.